StonvexLoading…
StonvexCore line items from M's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $21.76B | $22.29B | $23.09B | $24.44B |
Operating Income | $1.03B | $909.00M | $301.00M | $1.69B |
Net Income | $642.00M | $582.00M | $45.00M | $1.15B |
EPS (Diluted) | $2.32 | $2.07 | $0.16 | $4.08 |
Total Assets | $16.24B | $16.40B | $16.25B | $16.87B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.25B | $1.31B | $1.03B | $862.00M |
Free Cash Flow OCF − CapEx | $1.06B | $760.00M | $674.00M | $727.00M |
Shares Outstanding | 263.00M | 277.69M | 274.23M | 271.35M |